Preview: Tenet Healthcare's Earnings
Tenet Healthcare (NYSE:THC) is preparing to release its quarterly earnings on Wednesday, 2026-02-11. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Tenet Healthcare to report an earnings per share (EPS) of $4.06.
Anticipation surrounds Tenet Healthcare's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Earnings History Snapshot
The company's EPS beat by $0.36 in the last quarter, leading to a 2.21% increase in the share price on the following day.
Here's a look at Tenet Healthcare's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 3.34 | 2.86 | 3.14 | 2.83 |
| EPS Actual | 3.70 | 4.02 | 4.36 | 3.44 |
| Price Change % | 2.00 | 2.00 | 3.00 | 6.00 |
Tenet Healthcare Share Price Analysis
Shares of Tenet Healthcare were trading at $192.96 as of February 09. Over the last 52-week period, shares are up 53.02%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Insights Shared by Analysts on Tenet Healthcare
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Tenet Healthcare.
Tenet Healthcare has received a total of 7 ratings from analysts, with the consensus rating as Outperform. With an average one-year price target of $241.57, the consensus suggests a potential 25.19% upside.
Comparing Ratings with Competitors
In this comparison, we explore the analyst ratings and average 1-year price targets of Universal Health Services, Ensign Group and Encompass Health, three prominent industry players, offering insights into their relative performance expectations and market positioning.
- Analysts currently favor an Buy trajectory for Universal Health Services, with an average 1-year price target of $255.0, suggesting a potential 32.15% upside.
- Analysts currently favor an Outperform trajectory for Ensign Group, with an average 1-year price target of $214.33, suggesting a potential 11.07% upside.
- Analysts currently favor an Outperform trajectory for Encompass Health, with an average 1-year price target of $153.0, suggesting a potential 20.71% downside.
Comprehensive Peer Analysis Summary
The peer analysis summary outlines pivotal metrics for Universal Health Services, Ensign Group and Encompass Health, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.
| Company | Consensus | Revenue Growth | Gross Profit | Return on Equity |
|---|---|---|---|---|
| Tenet Healthcare | Outperform | 3.18% | $4.36B | 8.81% |
| Universal Health Services | Buy | 13.43% | $4.08B | 5.25% |
| Ensign Group | Outperform | 20.17% | $222.32M | 4.39% |
| Encompass Health | Outperform | 4.54% | $1.41B | 6.07% |
Key Takeaway:
Tenet Healthcare ranks highest in gross profit among its peers. It is in the middle for consensus rating and revenue growth. Tenet Healthcare has the highest return on equity compared to its peers.
Delving into Tenet Healthcare's Background
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
A Deep Dive into Tenet Healthcare's Financials
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Tenet Healthcare's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately 3.18%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 6.47%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 8.81%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Tenet Healthcare's ROA stands out, surpassing industry averages. With an impressive ROA of 1.18%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 3.29, caution is advised due to increased financial risk.
To track all earnings releases for Tenet Healthcare visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.